The current practice of administering prevention surgery for women with breast cancers in the BRCA1 and BRCA2 mutation bracket may have different results that previously expected. The risks are the same yet they may have different effects which may outweigh the risks of having the surgery in the first place. The study factored in the effect of genetics into the equation which was not considered in the past and it shows that a family history of the disease in women may provide varied results for sufferers. The cancer reducing operation coupled with the intake of cancer fighting drugs has produced results but this new study shows that the two types have different risks involved and that two different approaches should be devised for successful prevention and treatment.